Literature DB >> 10722692

JAB1 interacts with both the progesterone receptor and SRC-1.

A Chauchereau1, M Georgiakaki, M Perrin-Wolff, E Milgrom, H Loosfelt.   

Abstract

JAB1 (Jun activation domain-binding protein-1) has previously been described as a coactivator of AP1 transcription factor. We show here, by yeast and mammalian two-hybrid analyses and by pull-down experiments, that JAB1 also interacts with both the progesterone receptor (PR) and the steroid receptor coactivator 1 (SRC-1) and that it stabilizes PR-SRC-1 complexes. We also show that JAB1 potentiates the activity of a variety of transcription factors known to associate with SRC-1 (nuclear receptors, activator protein-1, and nuclear factor kappaB). This occurs without any modification of PR or SRC-1 concentration. JAB1 is a subunit of a large multiprotein complex that has been called the COP9 signalosome. The latter is present in plant and animal cells and has been shown to be involved in a variety of cellular mechanisms including transcription regulation, cell cycle control, and phosphorylation cascades. We now show that it is also involved in the mechanisms of action of nuclear receptors and of their coactivators.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722692     DOI: 10.1074/jbc.275.12.8540

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Jab1/CSN5 mediates E2F dependent expression of mitotic and apoptotic but not DNA replication targets.

Authors:  Huarui Lu; Xudong Liang; Olga A Issaenko; Timothy C Hallstrom
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

2.  Ligand-dependent degradation of SRC-1 is pivotal for progesterone receptor transcriptional activity.

Authors:  Larbi Amazit; Audrey Roseau; Junaid A Khan; Anne Chauchereau; Rakesh K Tyagi; Hugues Loosfelt; Philippe Leclerc; Marc Lombès; Anne Guiochon-Mantel
Journal:  Mol Endocrinol       Date:  2011-01-27

3.  Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes.

Authors:  Borja Belandia; Rob L Orford; Helen C Hurst; Malcolm G Parker
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

4.  Involvement of {beta}-catenin and unusual behavior of CBP and p300 in glucocorticosteroid signaling in Schwann cells.

Authors:  Cosima Fonte; Julien Grenier; Amalia Trousson; Anne Chauchereau; Olivier Lahuna; Etienne-Emile Baulieu; Michael Schumacher; Charbel Massaad
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

5.  Steroid receptor coactivator 3 regulates autophagy in breast cancer cells through macrophage migration inhibitory factor.

Authors:  Mei-Yi Wu; Junjiang Fu; Jianming Xu; Bert W O'Malley; Ray-Chang Wu
Journal:  Cell Res       Date:  2012-03-20       Impact factor: 25.617

6.  Genome-wide analysis and proteomic studies reveal APE1/Ref-1 multifunctional role in mammalian cells.

Authors:  Carlo Vascotto; Laura Cesaratto; Leo A H Zeef; Marta Deganuto; Chiara D'Ambrosio; Andrea Scaloni; Milena Romanello; Giuseppe Damante; Giulio Taglialatela; Daniela Delneri; Mark R Kelley; Sankar Mitra; Franco Quadrifoglio; Gianluca Tell
Journal:  Proteomics       Date:  2009-02       Impact factor: 3.984

7.  JAB1/CSN5: a new player in cell cycle control and cancer.

Authors:  Terry J Shackleford; Francois X Claret
Journal:  Cell Div       Date:  2010-10-18       Impact factor: 5.130

Review 8.  Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family.

Authors:  Jianming Xu; Ray-Chang Wu; Bert W O'Malley
Journal:  Nat Rev Cancer       Date:  2009-09       Impact factor: 60.716

9.  Deletion of macrophage migration inhibitory factor worsens stroke outcome in female mice.

Authors:  L Christine Turtzo; Jun Li; Rebecca Persky; Sharon Benashski; Gillian Weston; Richard Bucala; Venugopal Reddy Venna; Louise D McCullough
Journal:  Neurobiol Dis       Date:  2013-01-30       Impact factor: 5.996

10.  Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer.

Authors:  Eva Verjans; Erik Noetzel; Nuran Bektas; Anke K Schütz; Hongqi Lue; Birgitt Lennartz; Arndt Hartmann; Edgar Dahl; Jürgen Bernhagen
Journal:  BMC Cancer       Date:  2009-07-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.